Kyle Mikson CFA, an analyst from Canaccord Genuity, maintained the Buy rating on 10x Genomics (TXG – Research Report). The associated ...

Genomics Inc (NASDAQ:TXG) stock is trading lower after the company, on Wednesday, released preliminary financial results for ...

Bionano Genomics (NASDAQ:BNGO) expects revenue for the Q3 of 2024 to be between $6.5 and $6.8M vs. consensus of $7.85M, down ...

For the biopharma industry to match the pace of genomic innovations and speed new therapies to market, it will need to ...

Tesla stock edges higher ahead of the electric-vehicle maker’s highly anticipated Robotaxi Day, while Delta shares fall after ...

TD Cowen analyst Daniel Brennan maintained a Hold rating on 10x Genomics (TXG – Research Report) today and set a price target of $20.00. The company’s shares closed yesterday at $20.81. Brennan covers ...

Yuin man Professor Alex Brown's research into Indigenous genomics has been recognised with a fellowship with the Australian ...

The Pleasanton, Calif., life-science technology company said it expects to post third-quarter revenue of about $151.7 million, down 1% from last year's period. Analysts surveyed by FactSet are ...

Paresh Rajwat, Meta's former Pacific Northwest head of office. (LinkedIn Photo) Paresh Rajwat stepped down from his role as ...

Genomics has impressive financials but isn't expected to be profitable until at least 2028. Read more to see why I'm bearish ...

The human microbiome plays a critical role in our health, influencing everything from disease development to treatment ...